Cerebral Arterial Diseases D002539

Description

Pathological conditions of intracranial ARTERIES supplying the CEREBRUM. These diseases often are due to abnormalities or pathological processes in the ANTERIOR CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY; and POSTERIOR CEREBRAL ARTERY.   MeSH

Hierarchy View

Subtype Terms (6)

CADASIL
9 drugs (6 approved, 3 experimental)

Cerebral Amyloid Angiopathy
7 drugs (3 approved, 4 experimental)

Infarction, Anterior Cerebral Artery
3 drugs (1 approved, 2 experimental)

Infarction, Middle Cerebral Artery
16 drugs (8 approved, 8 experimental)

Infarction, Posterior Cerebral Artery
2 experimental drugs

Moyamoya Disease
6 drugs (5 approved, 1 experimental)


Approved Indicated Drugs (1)


Organization Involved with Phase 3 Indications (2)

Organization Involved with Phase 1 Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.